Sells custom-fabricated, muscle-signal-controlled arm braces to people with neuromuscular disorders and upper-limb paralysis.
10-K for FY2025, filed Mar 9, 2026
For direct-to-patient braces, Myomo bills the patient's insurer and records a sale after delivery and initial instruction. O&P providers and the VA buy devices, with sales recorded at shipment or delivery depending on the agreement.
10-K for FY2025, filed Mar 9, 2026The Company derives the majority of its revenue from direct billing. The Company also derives revenue from the sale of its products to…View ↗
The product has been delivered to the patient, including completion of initial instruction on its use.View ↗
For revenues derived from O&P providers in the United States and internationally and the VA, the Company recognizes revenue when control…View ↗
$40.9M
10-K for FY2025, filed Mar 9, 2026
$40.9M ↗
Myomo serves patients directly, evaluating and fitting them and billing their insurers. It also sells through orthotics and prosthetics providers and through the VA, whose staff fit devices for veterans.
10-K for FY2025, filed Mar 9, 2026We are a wearable medical robotics company that offers functional improvement for those with neuromuscular disorders and upper limb…View ↗
In many cases, private health insurance companies reimburse providers for the MyoPro device. If we are serving the patient directly, then…View ↗
Fabrication typically takes less than 2 weeks. Once the brace is fabricated, it is delivered to the patient either by us, an O&P practice…View ↗
No. It lost $15.6M in FY2025.
10-Q for Q3 FY2026, filed Nov 9, 2026
−$4.2MView ↗
8-K, filed Nov 9, 2026
Narrowing full-year revenue guidance to $46-47 million, at the upper end of previous guidanceView ↗
Growing. Revenue grew 3.0x in 4 years, from $13.9M in FY2021 to $40.9M in FY2025, about 31% a year.
Product updates
The product line has added an enhanced flagship brace with easier donning and software updates; the older report described the MyoPro as a custom-fabricated arm brace.
10-K for FY2022, filed Mar 13, 2023 10-K for FY2025, filed Mar 9, 2026We are a wearable medical robotics company that offers functional improvement for those with neuromuscular disorders and upper limb…View ↗
We have continually enhanced our product offerings by increasing functionality for users by the addition of a multi-articulated wrist and…View ↗
Competes with Lifeward, Ekso Bionics, Cyberdyne, MicroTransponder, Neurolutions, Vincent Systems, and HKK Bionics
10-K for FY2025, filed Mar 9, 2026During the last few years, a number of companies have emerged to provide exoskeleton suits that enable those with lower extremity paralysis…View ↗
Loading...